Resultats de la cerca - Christopher Alvarez‐Breckenridge
- Mostrar 1 - 20 resultats de 21
- Anar a la pàgina següent
-
1
-
2
-
3
Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients per Christopher Alvarez‐Breckenridge, Jordi Remón, Yolanda Piña, Edwin Nieblas‐Bedolla, Peter Forsyth, Lizza Hendriks, Priscilla K. Brastianos
Publicat 2022Artigo -
4
-
5
The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of... per Christopher Alvarez‐Breckenridge, Jianhua Yu, Richard L. Price, Wei Min, Yan Wang, Michal O. Nowicki, Yoonhee P. Ha, Stephen M. Bergin, Christine Hwang, Soledad Fernández, Balveen Kaur, Michael A. Caligiuri, E. Antonio Chiocca
Publicat 2012Artigo -
6
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control per Christopher Alvarez‐Breckenridge, Anita Giobbie‐Hurder, Corey M. Gill, Mia Bertalan, Jackson H. Stocking, Alexander Kaplan, Naema Nayyar, Donald P. Lawrence, Keith T. Flaherty, Helen A. Shih, Kevin Oh, Tracy T. Batchelor, Daniel P. Cahill, Ryan J. Sullivan, Priscilla K. Brastianos
Publicat 2019Artigo -
7
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors per Christopher Alvarez‐Breckenridge, Jianhua Yu, Richard L. Price, Jeffrey Wojton, Jason Pradarelli, Hsiaoyin Mao, Wei Min, Yan Wang, Shun He, Jayson Hardcastle, Soledad Fernández, Balveen Kaur, Sean E. Lawler, Éric Vivier, Ofer Mandelboim, Alessandro Moretta, Michael A. Caligiuri, E. Antonio Chiocca
Publicat 2012Artigo -
8
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human per Jianhua Yu, Takeki Mitsui, Wei Min, Hsiaoyin Mao, Jonathan P. Butchar, Mithun Vinod Shah, Jianying Zhang, Anjali Mishra, Christopher Alvarez‐Breckenridge, Xingluo Liu, Shu‐Jun Liu, Akihiko Yokohama, Rossana Trotta, Guido Marcucci, Don M. Benson, Thomas P. Loughran, Susheela Tridandapani, Michael A. Caligiuri
Publicat 2011Artigo -
9
Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations per Richard L. Price, Jieun Song, Katherine Bingmer, Tae Hyong Kim, Ji-Yeun Yi, Michal O. Nowicki, Xiaokui Mo, Todd Hollon, Eric Murnan, Christopher Alvarez‐Breckenridge, Soledad Fernández, Balveen Kaur, Andreana L. Rivera, Michael Oglesbee, Charles H. Cook, E. Antonio Chiocca, Chang‐Hyuk Kwon
Publicat 2013Artigo -
10
MicroRNAs activate natural killer cells through Toll-like receptor signaling per Shun He, Jianhong Chu, Lai‐Chu Wu, Hsiaoyin Mao, Yong Peng, Christopher Alvarez‐Breckenridge, Tiffany Hughes, Wei Min, Jianying Zhang, Shunzong Yuan, Sumeet Sandhu, Sumithira Vasu, Don M. Benson, Craig C. Hofmeister, Xiaoming He, Kalpana Ghoshal, Steven M. Devine, Michael A. Caligiuri, Jianhua Yu
Publicat 2013Artigo -
11
The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i>-Mutant Breast Cancer Brain Metastases per Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, Alexandria L. Fink, Ivanna V. Bihun, Matthew Lastrapes, Tristan Penson, Stephen Schmidt, Gregory R. Wojtkiewicz, Jianfang Ning, Megha Subramanian, Anita Giobbie‐Hurder, Maria Martinez‐Lage, Scott L. Carter, Daniel P. Cahill, Hiroaki Wakimoto, Priscilla K. Brastianos
Publicat 2019Artigo -
12
Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma per Andrew J. Bishop, Behrang Amini, Heather Lin, Shaan M. Raza, Shreyaskumar Patel, David R. Grosshans, Amol J. Ghia, Ahsan Farooqi, B. Ashleigh Guadagnolo, Devarati Mitra, Kadir C. Akdemir, Alexander J. Lazar, Wei‐Lien Wang, Christopher Alvarez‐Breckenridge, Justin E. Bird, Laurence D. Rhines, Neeta Somaiah, Anthony P. Conley
Publicat 2022Artigo -
13
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry per Teresa T. Nguyen, Dong Ho Shin, Sagar Sohoni, Sanjay K. Singh, Yisel Rivera-Molina, Hong Jiang, Xuejun Fan, Joy Gumin, Frederick F. Lang, Christopher Alvarez‐Breckenridge, Filipa Godoy‐Vitorino, Lisha Zhu, W. Jim Zheng, Lijie Zhai, Erik Ladomersky, Kristen L. Lauing, Marta M. Alonso, Derek A. Wainwright, Candelaria Gómez-Manzano, Juàn Fueyo
Publicat 2022Artigo -
14
Role of Posterior Carbon Fiber Implants in Spine Tumor Surgery per Christopher Alvarez‐Breckenridge, Robert Y. North, Claudio E. Tatsui, Naresh Kumar, Sheng-Fu Larry Lo, Mohammed Karim, J Reynolds, Áron Lazáry, Ilya Laufer, Jorrit Jan Verlaan, Ziya L. Gokaslan, Alessandro Luzzati, Riccardo Cecchinato, John H. Shin, Francis J. Hornicek, Alexander C. Disch, Matthew L. Goodwin, C. Rory Goodwin, Arjun Sahgal, Alessandro Gasbarrini, Stefano Boriani
Publicat 2025Artigo -
15
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor per Christopher Alvarez‐Breckenridge, Julie J. Miller, Naema Nayyar, Corey M. Gill, Andrew Kaneb, Megan R. D’Andrea, Long P. Le, Jesse Lee, Ju Cheng, Zongli Zheng, William E. Butler, Pratik S. Multani, Edna Chow Maneval, Sun Ha Paek, Brian Toyota, Dora Dias‐Santagata, Sandro Santagata, Javier M. Romero, Alice T. Shaw, Anna F. Farago, Stephen Yip, Daniel P. Cahill, Tracy T. Batchelor, A. John Iafrate, Priscilla K. Brastianos
Publicat 2017Artigo -
16
Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid per Michael White, Robert H. Klein, Brian Shaw, Albert Kim, Megha Subramanian, Joana L. Mora, Anita Giobbie‐Hurder, Deepika Nagabhushan, Aarushi Jain, Mohini Singh, Benjamin M. Kuter, Naema Nayyar, Mia Bertalan, Jackson H. Stocking, Samuel C. Markson, Matthew Lastrapes, Christopher Alvarez‐Breckenridge, Daniel P. Cahill, Gregory Gydush, Justin Rhoades, Denisse Rotem, Viktor A. Adalsteinsson, Maura Mahar, Alexander Kaplan, Kevin Oh, Ryan J. Sullivan, Elizabeth R. Gerstner, Scott L. Carter, Priscilla K. Brastianos
Publicat 2021Artigo -
17
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis per Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Forst, April F. Eichler, Beth Overmoyer, Nancy U. Lin, Wendy Y. Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo‐Jack, Michael White, Jörg Dietrich, Naema Nayyar, Albert E. Kim, Christopher Alvarez‐Breckenridge, Maura Mahar, Joana L. Mora, Brian V. Nahed, Pamela S. Jones, Helen A. Shih, Elizabeth R. Gerstner, Anita Giobbie‐Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan
Publicat 2021Artigo -
18
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases per Sanjay M. Prakadan, Christopher Alvarez‐Breckenridge, Samuel C. Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar, Andrew W. Navia, Benjamin M. Kuter, Kellie E. Kolb, Ivanna V. Bihun, Joana L. Mora, Mia Bertalan, Brian Shaw, Michael White, Alexander Kaplan, Jackson H. Stocking, Marc H. Wadsworth, Eudocia Q. Lee, Ugonma Chukwueke, Nancy Wang, Megha Subramanian, Denisse Rotem, Daniel P. Cahill, Viktor A. Adalsteinsson, Jeffrey W. Miller, Ryan J. Sullivan, Scott L. Carter, Priscilla K. Brastianos, Alex K. Shalek
Publicat 2021Artigo -
19
Evolution of delayed resistance to immunotherapy in a melanoma responder per David Liu, Jia‐Ren Lin, Emily Robitschek, Gyulnara G. Kasumova, Alex Heyde, Alvin Shi, Adam Kraya, Gao Zhang, Tabea Moll, Dennie T. Frederick, Yu‐An Chen, Shu Wang, Denis Schapiro, Li-Lun Ho, Kevin Bi, Avinash Sahu, Shaolin Mei, Benchun Miao, Tatyana Sharova, Christopher Alvarez‐Breckenridge, Jackson H. Stocking, Tommy Kim, Riley Fadden, Donald P. Lawrence, Mai P. Hoang, Daniel P. Cahill, Mohsen Malehmir, Martin A. Nowak, Priscilla K. Brastianos, Christine G. Lian, Eytan Ruppin, Benjamin Izar, Meenhard Herlyn, Eliezer M. Van Allen, Katherine L. Nathanson, Keith T. Flaherty, Ryan J. Sullivan, Manolis Kellis, Peter K. Sorger, Genevieve M. Boland
Publicat 2021Artigo -
20
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma per David Shih, Naema Nayyar, Ivanna V. Bihun, Ibiayi Dagogo‐Jack, Corey M. Gill, Elisa Aquilanti, Mia Bertalan, Alexander Kaplan, Megan R. D’Andrea, Ugonma Chukwueke, Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Nicholas D. Camarda, Matthew Lastrapes, Devin McCabe, Ben Kuter, Benjamin Kaufman, Matthew R. Strickland, Juan Carlos Martínez-Gutiérrez, Deepika Nagabhushan, Magali de Sauvage, Michael White, Brandyn Castro, Kaitlin Hoang, Andrew Kaneb, Emily Batchelor, Sun Ha Paek, Sun Hye Park, Maria Martinez‐Lage, Anna S. Berghoff, Parker Merrill, Elizabeth R. Gerstner, Tracy T. Batchelor, Matthew P. Frosch, Ryan P. Frazier, Darrell R. Borger, A. John Iafrate, Bruce E. Johnson, Sandro Santagata, Matthias Preusser, Daniel P. Cahill, Scott L. Carter, Priscilla K. Brastianos
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Medicine
Cancer research
Biology
Immunology
Internal medicine
Cancer
Immune system
Immunotherapy
Oncology
Gene
Genetics
Biochemistry
Brain metastasis
Immune checkpoint
Melanoma
Metastasis
Oncolytic virus
Receptor
Surgery
Tumor microenvironment
Virology
Blockade
Cell biology
Disease
Glioma
Ipilimumab
Breast cancer
Cerebrospinal fluid
Clinical trial
Context (archaeology)